Eric Dobmeier, President, CEO at CHINOOK THERAPEUTICS, INC. (KDNY), sold 55,000 shares at $22.31 ($669K) on 2022-12-01, disclosed to the SEC on 2022-12-02.
Open-market sale of $669k KDNY by President, CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 25,000 | $0 | 0.0% |
| 2 | $22.31 | 30,000 | $669K | 100.0% |
| Total | $12.17 avg | 55,000 | $669K | 100% |
| Filing → |
| KDNY | SELL | 2023-02-15 | $385K | — | Filing → |
| KDNY | SELL | 2023-02-01 | $993K | — | Filing → |
| KDNY | BUY | 2022-05-27 | $65K | — | Filing → |